journal cover

ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up

Transplantation

Jun 27, 2008

Helena GenbergGunnar Tydén

Download from

Publisher
PubMed

Abstract

In 2001 a protocol for ABO-incompatible (ABOi) kidney transplantation based on antigen-specific immunoadsorption and rituximab was introduced at our center, short-term results being comparable with those of ABO-compatible (ABOc) living donor kidney transplantation. Of greater importance...read more

Mentioned in this Paper

Prevalence Studies
Monoclonal Antibodies
Creatinine
Blood Group H Type 1 Antigen
Graft Survival
Glomerular Filtration Rate
Antigens
Graft Rejection
Immunosorbents
Mabthera
Paper Details
References
  • References30
  • Citations94
123
  • References30
  • Citations94
12345...

Feeds With Similar Papers

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

Graft Rejection

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

© 2020 Meta ULC. All rights reserved

ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up

Transplantation

Jun 27, 2008

Helena GenbergGunnar Tydén

PMID: 18580466

DOI: 10.1097/tp.0b013e3181726849

Abstract

In 2001 a protocol for ABO-incompatible (ABOi) kidney transplantation based on antigen-specific immunoadsorption and rituximab was introduced at our center, short-term results being comparable with those of ABO-compatible (ABOc) living donor kidney transplantation. Of greater importance...read more

Mentioned in this Paper

Prevalence Studies
Monoclonal Antibodies
Creatinine
Blood Group H Type 1 Antigen
Graft Survival
Glomerular Filtration Rate
Antigens
Graft Rejection
Immunosorbents
Mabthera

Feeds With Similar Papers

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

Graft Rejection

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

Related Papers

Paper Details
References
  • References30
  • Citations94
123
  • References30
  • Citations94
12345...

Download from

Publisher
PubMed
/papers/abo-incompatible-kidney-transplantation-using/18580466